Armata Pharmaceuticals (ARMP) Common Equity (2016 - 2026)
Quarterly results put Common Equity at -$311.6 million for Q1 2026, down 479.34% from a year ago — trailing twelve months through Mar 2026 was -$311.6 million (down 479.34% YoY), and the annual figure for FY2025 was -$218.6 million, down 355.23%.
Armata Pharmaceuticals has reported Common Equity over the past 14 years, most recently at -$311.6 million for Q1 2026.
- Common Equity reached -$311.6 million in Q1 2026 per ARMP's latest filing, down from -$218.6 million in the prior quarter.
- Across five years, Common Equity topped out at $61.5 million in Q1 2022 and bottomed at -$311.6 million in Q1 2026.
- Median Common Equity over the past 5 years was -$46.1 million (2024), compared with a mean of -$44.5 million.
- The largest annual shift saw Common Equity surged 91.86% in 2022 before it tumbled 479.34% in 2026.
- Over 5 years, Common Equity stood at $36.1 million in 2022, then crashed by 188.87% to -$32.1 million in 2023, then tumbled by 49.76% to -$48.0 million in 2024, then crashed by 355.23% to -$218.6 million in 2025, then tumbled by 42.54% to -$311.6 million in 2026.
- Business Quant data shows Common Equity for ARMP at -$311.6 million in Q1 2026, -$218.6 million in Q4 2025, and -$95.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -311.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -311.59 Mn |
| Dec 31, 2025 | -218.60 Mn |
| Sep 30, 2025 | -95.59 Mn |
| Jun 30, 2025 | -69.50 Mn |
| Mar 31, 2025 | -53.78 Mn |
| Dec 31, 2024 | -48.02 Mn |
| Sep 30, 2024 | -50.97 Mn |
| Jun 30, 2024 | -46.10 Mn |
| Mar 31, 2024 | -56.51 Mn |
| Dec 31, 2023 | -32.07 Mn |
| Sep 30, 2023 | -12.39 Mn |
| Jun 30, 2023 | 19.14 Mn |
| Mar 31, 2023 | 22.45 Mn |
| Dec 31, 2022 | 36.08 Mn |
| Sep 30, 2022 | 45.58 Mn |
| Jun 30, 2022 | 53.29 Mn |
| Mar 31, 2022 | 61.54 Mn |
| Dec 31, 2021 | 25.40 Mn |
| Sep 30, 2021 | 23.76 Mn |
| Jun 30, 2021 | 28.62 Mn |
| Mar 31, 2021 | 34.01 Mn |
| Dec 31, 2020 | 18.86 Mn |
| Sep 30, 2020 | 24.62 Mn |
| Jun 30, 2020 | 29.64 Mn |
| Mar 31, 2020 | 33.48 Mn |
| Dec 31, 2019 | 14.59 Mn |
| Sep 30, 2019 | 18.13 Mn |
| Jun 30, 2019 | 22.63 Mn |
| Mar 31, 2019 | 3.96 Mn |
| Dec 31, 2018 | 7.69 Mn |
| Sep 30, 2018 | 8.80 Mn |
| Jun 30, 2018 | 11.56 Mn |
| Mar 31, 2018 | 14.71 Mn |
| Dec 31, 2017 | 24.34 Mn |
| Sep 30, 2017 | 9.76 Mn |
| Jun 30, 2017 | 9.86 Mn |
| Mar 31, 2017 | 6.65 Mn |
| Dec 31, 2016 | 9.72 Mn |
| Sep 30, 2016 | 18.23 Mn |
| Jun 30, 2016 | 21.48 Mn |